Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Adryan A Perez , Frank W Woo , Darren C Tsang , et al Added: 3 years ago
The use of cardiovascular implantable electronic devices (CIEDs) has increased dramatically, with approximately 1.2–­1.4 million CIEDs implanted annually worldwide.1 In the US alone, there are more patients with CIEDs than registered nurses.2,3 CIEDs use leads that connect a generator to cardiac tissue to treat patients with many conditions including symptomatic bradycardia, morbid tachycardia… View more
Author(s): Angelo Auricchio , François Regoli , Giulio Conte , et al Added: 3 years ago
The number of cardiovascular implantable electronic devices (CIEDs) has increased progressively during the past decades, with a parallel increase in the demand for transvenous lead extraction (TLE). Indication and class of recommendation for TLE have been extensively discussed in a recent expert consensus document.1 With the exception of a few prospectively conducted registries,2,3 the vast… View more
Author(s): Roger Carillo Added: 6 years ago
Roger Carillo (University of Miami Hospital, Miami, US) discusses the multi-year evaluation of compliant endovascular balloon in treating superior vena cava tears during transvenous lead extraction at EHRA 2018. Filmed by Radcliffe Cardiology on-site at EHRA 2018. View more
Author(s): Jeff Healey Added: 1 year ago
In this short interview, Dr Jeff Healey (McMaster University, Hamilton, CA) talks about the key data from the ATLAS (Avoid Transvenous Leads in Appropriate Subjects) trial (NCT02881255).The aim of the study was to compare standard, single chamber transvenous ICD (TV-ICD) to sub-cutaneous ICD (S-ICD) (Boston Scientific EMBLEM) in occurrence of perioperative and long term device related… View more
Author(s): Justin Hayase , Duc H Do , Noel G Boyle Added: 3 years ago
The ICD is an important therapy for both primary and secondary prevention of sudden cardiac death in selected patients. The role for defibrillation threshold (DFT) testing either intraoperatively or postoperatively has changed significantly over the past few decades, and it is no longer routinely recommended in patients undergoing left-sided transvenous ICD implantation.1–7 The definition of the… View more
Research Area(s) / Expertise:

Heart Failure

Job title: Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve… View more
Author(s): Pugazhendhi Vijayaraman Added: 1 year ago
Dr Pugazhendi Vijayaraman (Geisinger Heart Institute, Wilkes-Barre, Pennsylvania, US) joins us from HRS 2022 to discuss the real-world data from an international study assessing the outcomes of rescue LBBAP in patients with coronary sinus lead failure, or those who did not respond to BIV-CRT. Discussion points: 1. Importance of this study 2. Patient cohort, study design and endpoints 3. Key… View more